Paper6587901
Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
Lilleyman JS and 4 others. Br J Cancer, 1984. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization. Papers, record 6587901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6587901
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Guanine Nucleotides | Major topic |
| Leukemia, Lymphoid | Major topic |
| Mercaptopurine | Major topic |
| Thionucleotides | Major topic |
| Adolescent | |
| Child | |
| Child, Preschool | |
| Erythrocytes | |
| Female | |
| Humans | |
| Leukocyte Count | |
| Male | |
| Neutrophils | |
| Sex Factors |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4856046 | A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. | Cancer Res | 1974 | https://conductscience.org/library/papers/4856046 | PubMed |
| 2 | 282457 | A reappraisal of the results of stopping therapy in childhood leukemia. | N Engl J Med | 1979 | https://conductscience.org/library/papers/282457 | PubMed |
| 3 | 371785 | The ninth annual David Karnofsky Lecture. Treatment of acute lymphocytic leukemia. | Cancer | 1979 | https://conductscience.org/library/papers/371785 | PubMed |
| 4 | 7192152 | Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7192152 | PubMed |
| 5 | 7016165 | Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. | Br J Haematol | 1981 | https://conductscience.org/library/papers/7016165 | PubMed |
| 6 | 6954968 | 6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia. | Br J Cancer | 1982 | https://conductscience.org/library/papers/6954968 | PubMed |
| 7 | 6131958 | Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells. | J Pharm Pharmacol | 1983 | https://conductscience.org/library/papers/6131958 | PubMed |
| 8 | 6607783 | Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemia. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6607783 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37641095 | Global comparative transcriptomes uncover novel and population-specific gene expression in esophageal squamous cell carcinoma. | Infect Agent Cancer | 2023 | https://conductscience.org/library/papers/37641095 | PubMed |
| 36238550 | Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising "MINT" sequencing strategy and therapeutic "DNA-TG" monitoring. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36238550 | PubMed |
| 33481917 | DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes. | PLoS One | 2021 | https://conductscience.org/library/papers/33481917 | PubMed |
| 32668748 | Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis. | J Clin Med | 2020 | https://conductscience.org/library/papers/32668748 | PubMed |
| 21372841 | Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia. | Leukemia | 2011 | https://conductscience.org/library/papers/21372841 | PubMed |
| 12959304 | Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia. | Br J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/12959304 | PubMed |
| 8453958 | Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. | Eur J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8453958 | PubMed |
| 7946931 | Thiopurine methyltransferase activity in a French population: h.p.l.c. assay conditions and effects of drugs and inhibitors. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7946931 | PubMed |
| 4044625 | 6-Thioguanine: high-dose 2-H infusions in goats. | J Cancer Res Clin Oncol | 1985 | https://conductscience.org/library/papers/4044625 | PubMed |
| 2031601 | Importance of 6-mercaptopurine dose in lymphoblastic leukaemia. | Arch Dis Child | 1991 | https://conductscience.org/library/papers/2031601 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6587901
GET https://conductscience.org/api/papers/v1/6587901/authors